[3-Methyl-2-(triazol-2-yl)phenyl]-[6-[[5-(trifluoromethyl)pyridin-2-yl]amino]-2-azabicyclo[2.2.1]heptan-2-yl]methanone

InChIKey	`TWMWEJVSFZPUFN-UHFFFAOYSA-N`
Compound Name	[3-Methyl-2-(triazol-2-yl)phenyl]-[6-[[5-(trifluoromethyl)pyridin-2-yl]amino]-2-azabicyclo[2.2.1]heptan-2-yl]methanone
Canonical SMILES	`Cc1cccc(C(=O)N2CC3CC(Nc4ccc(C(F)(F)F)cn4)C2C3)c1-n1nccn1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	2
Pfam Stratification	Homologous
Avg pChEMBL	7.93
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43613	HCRTR1	Homo sapiens	Human	PF00001	8.5	Ki	ChEMBL;BindingDB
O43614	HCRTR2	Homo sapiens	Human	PF00001 PF03827	7.3	Ki	ChEMBL;BindingDB